|
Market Closed -
NYSE
16:00:02 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 81.26 USD | +0.44% |
|
+3.28% | -6.93% |
| Market Cap | 10.91B 9.79B 9.05B 8.2B 15.31B 1,039B 15.5B 108B 43.1B 544B 40.94B 40.08B 1,726B | P/E 2026 * |
19.6x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 10.09B 9.05B 8.37B 7.58B 14.16B 961B 14.33B 100B 39.85B 503B 37.86B 37.06B 1,596B | EV / Sales 2026 * |
3.15x | EV / Sales 2027 * | 2.86x |
| Free-Float |
85.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| GMED | Delayed | |
CBOE
| GMED | Real-time | |
|
Tradegate
| GM0N | Real-time | |
|
Mexican S.E.
| GMED * | End-of-day quote | |
|
Deutsche Boerse AG
| GM0N | Delayed | |
|
Börse Stuttgart
| GM0N | Delayed | |
|
Boerse Muenchen
| GM0N | Real-time | |
|
Xetra
| GM0N | Delayed |
Last Transcript: Globus Medical, Inc.
| 1 day | +0.44% | ||
| 1 week | +3.28% | ||
| Current month | +8.49% | ||
| 1 month | +8.67% | ||
| 3 months | +0.84% | ||
| 6 months | -10.45% | ||
| Current year | -6.93% |
| 1 week | 80.06 |  | 82.02 |
| 1 month | 72.54 | | 82.02 |
| Current year | 72.54 | | 101.4 |
| 1 year | 59.51 | | 101.4 |
| 3 years | 43.38 | | 101.4 |
| 5 years | 43.38 | | 101.4 |
| 10 years | 19.25 | | 101.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 47 | 2025-07-17 |
Kyle Kline
DFI | Director of Finance/CFO | 41 | 2025-07-17 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 59 | 2002-12-31 |
David Davidar
BRD | Director/Board Member | 60 | 2002-12-31 |
Daniel Lemaitre
BRD | Director/Board Member | 72 | 2011-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Director | 90,000 | 0.0805% | ||
| 8/18/26 | Exercice | Director | 75,000 | 0.0662% | ||
| 7/27/26 | Don | Founder | -2,500 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.44% | +3.28% | +29.50% | +77.97% | 10.91B | |
| -0.45% | +2.12% | -18.93% | +10.54% | 178B | |
| +0.86% | +2.15% | -19.13% | +16.07% | 117B | |
| +0.88% | +1.88% | +1.66% | +36.51% | 116B | |
| +1.10% | +1.44% | -43.54% | +6.79% | 91.03B | |
| -0.31% | -4.72% | -3.36% | +72.86% | 61.89B | |
| -0.32% | -0.19% | +10.38% | +83.80% | 55.85B | |
| +0.07% | +0.42% | +5.94% | -22.43% | 53.16B | |
| +0.30% | +1.70% | -11.26% | +43.83% | 44.35B | |
| +0.88% | +0.66% | -2.02% | -7.82% | 33.59B | |
| Average | +0.35% | +1.18% | -5.08% | +31.81% | 76.1B | |
| Weighted average by Cap. | +0.31% | +1.28% | -11.72% | +25.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2B 2.87B 2.65B 2.4B 4.49B 305B 4.54B 31.73B 12.64B 159B 12.01B 11.75B 506B | 3.39B 3.04B 2.81B 2.55B 4.76B 323B 4.82B 33.65B 13.4B 169B 12.73B 12.46B 537B |
| Net income | 574M 515M 476M 431M 805M 54.65B 815M 5.69B 2.27B 28.6B 2.15B 2.11B 90.78B | 643M 577M 534M 483M 903M 61.28B 914M 6.38B 2.54B 32.06B 2.41B 2.36B 102B |
| Net Debt | -822M -738M -682M -618M -1.15B -78.32B -1.17B -8.16B -3.25B -40.99B -3.09B -3.02B -130B | -1.2B -1.07B -992M -899M -1.68B -114B -1.7B -11.86B -4.73B -59.62B -4.49B -4.39B -189B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | US$81.26 | +0.44% | 772,415 |
| 26-10-27 | US$80.90 | -1.14% | 634,839 |
| 26-10-26 | US$81.83 | +0.52% | 1,031,159 |
| 26-10-23 | US$81.41 | -0.31% | 768,462 |
| 26-10-22 | US$81.66 | +3.79% | 1,293,941 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
